Osteoneurogen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

Osteoneurogen General Information

Description

Developer of anti-fibrotic drugs intended to treat idiopathic pulmonary fibrosis (IPF), non-alcoholic steatohepatitis (NASH), and renal fibrosis. The company's platform uses a combination of traditional and cutting-edge technologies to develop novel anti-fibrotic drugs that are more effective and have fewer side effects than existing treatments, enabling the company to bring new hope to patients with fibrotic diseases.

Contact Information

Website
www.osteoneurogen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 1405, 212 Gasandigital 1-ro
  • Geumcheon-gu
  • Seoul, 08507
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Number 1405, 212 Gasandigital 1-ro
  • Geumcheon-gu
  • Seoul, 08507
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Osteoneurogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Apr-2026 Completed Product Development
2. Later Stage VC (Series A) 01-Jun-2020 Completed Product Development
1. Seed Round 01-Aug-2017 $1M $1M Completed Product Development
To view Osteoneurogen’s complete valuation and funding history, request access »

Osteoneurogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Osteoneurogen FAQs

  • When was Osteoneurogen founded?

    Osteoneurogen was founded in 2013.

  • Where is Osteoneurogen headquartered?

    Osteoneurogen is headquartered in Seoul, South Korea.

  • What is the size of Osteoneurogen?

    Osteoneurogen has 4 total employees.

  • What industry is Osteoneurogen in?

    Osteoneurogen’s primary industry is Drug Discovery.

  • Is Osteoneurogen a private or public company?

    Osteoneurogen is a Private company.

  • What is Osteoneurogen’s current revenue?

    The current revenue for Osteoneurogen is .

  • How much funding has Osteoneurogen raised over time?

    Osteoneurogen has raised $9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process